Duobrii

NDC 0187-0653, halobetasol propionate and tazarotene, lotion, from Bausch Health US, LLC.

Product NDC: 0187-0653
Status: Listed
Labeler: Bausch Health US, LLC
Dosage form: LOTION
Route: TOPICAL
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: NDA
Application: NDA209354
DEA schedule: None

Request

curl https://api.healthcare.dev/v1/drugs/ndc/0187-0653 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

HALOBETASOL PROPIONATE.1 mg/g
TAZAROTENE.45 mg/g

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Retinoid [EPC]; Retinoids [CS]

Package NDC	NDC-11	Package
0187-0653-01	00187065301	1 TUBE in 1 CARTON (0187-0653-01) / 100 g in 1 TUBE
0187-0653-03	00187065303	6 TUBE in 1 CARTON (0187-0653-03) / 3 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

2166094halobetasol propionate 0.1 MG/ML / tazarotene 0.45 MG/ML Topical Lotion [Duobrii] (SBD)

Related lookups

FDA label sections
GET /v1/drugs/labels/b3f0cdc0-69fd-43d1-baf2-d776a3a20715

Use it

Look up 0187-0653 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/ndc/0187-0653 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up NDC 0187-0653. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Get a free key NDC docs Connect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.